46 results
8-K
EX-1.1
ATOS
Atossa Therapeutics Inc
23 Mar 21
Entry into a Material Definitive Agreement
6:01am
of, the testing of, the sale of, or the labeling and promotion of any product of the Company, (ii) withdraws its approval of, requests the recall
8-K
EX-1.1
ATOS
Atossa Therapeutics Inc
8 Jan 21
Entry into a Material Definitive Agreement
9:00am
and promotion of any product of the Company, (ii) withdraws its approval of, requests the recall, suspension, or seizure of, or withdraws or orders
8-K
EX-1.1
ATOS
Atossa Therapeutics Inc
21 Dec 20
Entry into a Material Definitive Agreement
9:10am
of the Company, (ii) withdraws its approval of, requests the recall, suspension, or seizure of, or withdraws or orders the withdrawal of advertising or sales
8-K
EX-1.1
ATOS
Atossa Therapeutics Inc
14 Dec 20
Entry into a Material Definitive Agreement
4:16pm
and promotion of any product of the Company , (ii) withdraws its approval of, requests the recall, suspension, or seizure of, or withdraws or orders
8-K
EX-1.1
l26ol7
25 Sep 20
Entry into a Material Definitive Agreement
5:00pm
8-K
EX-1.1
dc7b 601w8eh4e
10 Feb 20
Entry into a Material Definitive Agreement
12:00am
8-K
EX-99.1
rj4sqtyl8iujftnq03x
12 Aug 14
Atossa Genetics Announces Second Quarter 2014 Financial Results
12:00am